1月2日，湖(hu)北(bei)省材(cai)(cai)流通追(zhui)溯(su)體(ti)系在(zai)武漢上線(xian)運行。目前該系統已有湖(hu)北(bei)九州通、李時(shi)珍中藥(yao)(yao)(yao)材(cai)(cai)市場等30家節點企(qi)業近600種藥(yao)(yao)(yao)材(cai)(cai)可追(zhui)溯(su)信息。消(xiao)費者可通過手(shou)機(ji)、互(hu)聯網(wang)、藥(yao)(yao)(yao)店終端掃描二維碼(ma)，了解到(dao)(dao)所(suo)購買中藥(yao)(yao)(yao)材(cai)(cai)從種植、加工(gong)到(dao)(dao)流通環節的全流程(cheng)情況。
2014年8月(yue)湖北(bei)省成(cheng)為第(di)三批中藥(yao)(yao)(yao)材(cai)流(liu)通(tong)追(zhui)溯(su)體系(xi)建設(she)省份,兩(liang)年來湖北(bei)省按照國家統(tong)一標準建設(she),運用(yong)(yong)現代化技(ji)術實現種(zhong)植、流(liu)通(tong)、生產(chan)、使用(yong)(yong)的全鏈條追(zhui)溯(su),鼓勵引導中藥(yao)(yao)(yao)飲片、中成(cheng)藥(yao)(yao)(yao)生產(chan)企業使用(yong)(yong)可追(zhui)溯(su)的中藥(yao)(yao)(yao)材(cai)為原(yuan)料,達到中藥(yao)(yao)(yao)材(cai)流(liu)通(tong)“來源可追(zhui)、去向可查、責任可究”。
“這個二維(wei)(wei)碼是唯(wei)一的(de)。”項(xiang)目建設(she)方負責人萬(wan)有綱舉例說,“假如企(qi)業這個月(yue)需要生(sheng)產1000包(bao)產品(pin),在生(sheng)產之(zhi)前要向中央(yang)系統(tong)提出申請,待中央(yang)系統(tong)審(shen)核批復(fu)后,再向企(qi)業提供這1000個二維(wei)(wei)碼。”省商務廳(ting)市場秩序處處長盧大珍(zhen)呼吁(yu)更(geng)多(duo)企(qi)業加(jia)入到該系統(tong),讓更(geng)多(duo)的(de)藥材(cai)可追(zhui)溯。
湖北(bei)省(sheng)商務廳統計數據顯示(shi),湖北(bei)省(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)現知(zhi)資源(yuan)種(zhong)(zhong)類(包括(kuo)常用(yong)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)、民間藥(yao)、民族藥(yao)物)達3970種(zhong)(zhong),約(yue)為(wei)全(quan)國中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)資源(yuan)12807種(zhong)(zhong)的(de)31%,居全(quan)國第5位。經(jing)營的(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)品種(zhong)(zhong)686種(zhong)(zhong),約(yue)為(wei)全(quan)國1200種(zhong)(zhong)的(de)57.2%。常用(yong)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong),80%以(yi)上為(wei)野生品種(zhong)(zhong),野生中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)平均(jun)年收(shou)購量(liang)2.1萬噸,居全(quan)國第6位。但是近年來,湖北(bei)乃(nai)至全(quan)國中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)流通(tong)領域存(cun)在(zai)缺(que)乏準(zhun)入(ru)標準(zhun)和(he)嚴格(ge)監(jian)管(guan),藥(yao)材(cai)的(de)來源(yuan)、晾曬(shai)、包裝、存(cun)儲、運(yun)輸(shu)等均(jun)無相應的(de)規(gui)范等問題。省(sheng)商務廳副巡視員王翔表示(shi),中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)流通(tong)追溯體系的(de)建(jian)立對中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)生產、流通(tong)和(he)需求(qiu)信(xin)息進行收(shou)集(ji),運(yun)用(yong)“大數據”進行分析,建(jian)立信(xin)息監(jian)測預警(jing),可以(yi)有(you)效抑制(zhi)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)價格(ge)無序上漲,推(tui)動中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)材(cai)流通(tong)方式(shi)向信(xin)息化轉(zhuan)變。